{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:35Z","timestamp":1784764835512,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.maturitas.2026.109037","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:05:09Z","timestamp":1782986709000},"page":"109037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnosis and management of androgen excess presenting after menopause"],"prefix":"10.1016","volume":"211","author":[{"given":"Andr\u00e9s E.","family":"Ortiz-Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2026.109037_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.maturitas.2026.109037_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000494909","article-title":"Androgens in menopausal women: not only polycystic ovary syndrome","volume":"53","author":"Kostakis","year":"2019","journal-title":"Front. Horm. Res."},{"issue":"8","key":"10.1016\/j.maturitas.2026.109037_bb0015","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s40618-023-02297-9","article-title":"Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience","volume":"47","author":"Luque-Ram\u00edrez","year":"2024","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109037_bb0020","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum. Reprod. Update"},{"issue":"8","key":"10.1016\/j.maturitas.2026.109037_bb0030","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/jc.2012-1683","article-title":"Management of postmenopausal virilization","volume":"97","author":"Alpanes","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0035","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-14-0468","article-title":"Hyperandrogenism after menopause","volume":"172","author":"Markopoulos","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109037_bb0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2007-1016244","article-title":"Aromatase in aging women","volume":"17","author":"Bulun","year":"1999","journal-title":"Semin. Reprod. Endocrinol."},{"issue":"8","key":"10.1016\/j.maturitas.2026.109037_bb0045","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1210\/jc.2007-0581","article-title":"Ovarian androgen production in postmenopausal women","volume":"92","author":"Fogle","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109037_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)60609-X","article-title":"Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study","volume":"51","author":"Gershagen","year":"1989","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2026.109037_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105972","article-title":"Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study","volume":"121","author":"Wang","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.maturitas.2026.109037_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0015-0282(16)56810-1","article-title":"The climacteric ovary as a functional gonadotropin-driven androgen-producing gland","volume":"62","author":"Adashi","year":"1994","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0300-595X(86)80021-4","article-title":"Adrenal and gonadal androgen secretion in normal females","volume":"15","author":"Longcope","year":"1986","journal-title":"Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.maturitas.2026.109037_bb0075","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/jc.2010-2959","article-title":"Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls","volume":"96","author":"Schmidt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e318185e249","article-title":"Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation","volume":"16","author":"Torr\u00e9ns","year":"2009","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.maturitas.2026.109037_bb0085","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109037_bb0090","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2008-2374","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis","volume":"94","author":"Nakamura","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109037_bb0095","doi-asserted-by":"crossref","DOI":"10.4172\/2167-0420.1000e132","article-title":"Postmenopausal hyperandrogenism","volume":"7","author":"Lal","year":"2018","journal-title":"J Womens Health Care"},{"issue":"11","key":"10.1016\/j.maturitas.2026.109037_bb0100","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1158\/1055-9965.EPI-21-0604","article-title":"Obesity, height, and serum androgen metabolism among postmenopausal women in the women\u2019s health initiative observational study","volume":"30","author":"Oh","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109037_bb0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4239\/wjd.v12.i5.616","article-title":"Role of insulin and insulin resistance in androgen excess disorders","volume":"12","author":"Unluhizarci","year":"2021","journal-title":"World J. Diabetes"},{"issue":"7","key":"10.1016\/j.maturitas.2026.109037_bb0110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","article-title":"Abdominal adiposity and the polycystic ovary syndrome","volume":"18","author":"Escobar-Morreale","year":"2007","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109037_bb0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmac011","article-title":"Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis","volume":"28","author":"Bayona","year":"2022","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.maturitas.2026.109037_bb0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humupd\/dmx012","article-title":"Prevalence of \u2018obesity-associated gonadal dysfunction\u2019 in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis","volume":"23","author":"Escobar-Morreale","year":"2017","journal-title":"Hum. Reprod. Update"},{"issue":"6865","key":"10.1016\/j.maturitas.2026.109037_bb0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.maturitas.2026.109037_bb0130","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1080\/14656566.2018.1528231","article-title":"Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes","volume":"19","author":"Ortiz-Flores","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"issue":"7","key":"10.1016\/j.maturitas.2026.109037_bb0135","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109037_bb0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2010-0130","article-title":"Hyperandrogenism in women with polycystic ovary syndrome persists after menopause","volume":"96","author":"Markopoulos","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109037_bb0145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmad015","article-title":"PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis","volume":"29","author":"Millan-de-Meer","year":"2023","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109037_bb0150","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/humupd\/dmx014","article-title":"Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women","volume":"23","author":"Carmina","year":"2017","journal-title":"Hum. Reprod. Update"},{"issue":"6","key":"10.1016\/j.maturitas.2026.109037_bb0155","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1067\/mob.2000.108020","article-title":"21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study","volume":"183","author":"Moran","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109037_bb0165","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1210\/clinem\/dgac673","article-title":"Approach to investigation of hyperandrogenism in a postmenopausal woman","volume":"108","author":"Hirschberg","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109037_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ecl.2020.12.002","article-title":"Postmenopausal Hyperandrogenism: evaluation and treatment strategies","volume":"50","author":"Zaman","year":"2021","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.maturitas.2026.109037_bb0175","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/IJWH.S475149","article-title":"Association between female androgen levels, metabolic syndrome, and cardiovascular disease: an NHANES analysis (2013-2016)","volume":"16","author":"Luo","year":"2024","journal-title":"Int. J. Women's Health"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2265.1997.1050916.x","article-title":"Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women","volume":"46","author":"Barth","year":"1997","journal-title":"Clin. Endocrinol."},{"issue":"5 Pt 2","key":"10.1016\/j.maturitas.2026.109037_bb0185","first-page":"893","article-title":"Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary","volume":"99","author":"Krug","year":"2002","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109037_bb0190","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/uog.6131","article-title":"Ovarian hyperthecosis on grayscale and color Doppler ultrasound","volume":"32","author":"Rousset","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109037_bb0195","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7863\/jum.2009.28.5.587","article-title":"Ovarian stromal hyperthecosis: sonographic features and histologic associations","volume":"28","author":"Brown","year":"2009","journal-title":"J. Ultrasound Med."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109037_bb0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2000.01117.x","article-title":"How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?","volume":"53","author":"Kaltsas","year":"2000","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"10.1016\/j.maturitas.2026.109037_bb0205","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jcem.84.8.5858","article-title":"Menstrual irregularity in women with acromegaly","volume":"84","author":"Kaltsas","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/en.2003-0940","article-title":"Valproate potentiates androgen biosynthesis in human ovarian theca cells","volume":"145","author":"Nelson-DeGrave","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0215","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/humrep\/den372","article-title":"Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies","volume":"24","author":"de Ronde","year":"2009","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109037_bb0220","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.surg.2004.06.046","article-title":"Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases","volume":"136","author":"Moreno","year":"2004","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2005.02.007","article-title":"Ovarian cancer incidence in the United States, 1992-1999","volume":"97","author":"Quirk","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0230","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.path.2019.02.005","article-title":"Practical review of ovarian sex cord-stromal tumors","volume":"12","author":"Hanley","year":"2019","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.maturitas.2026.109037_bb0235","series-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Kurman RJ","year":"2014"},{"issue":"1","key":"10.1016\/j.maturitas.2026.109037_bb0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"17","key":"10.1016\/j.maturitas.2026.109037_bb0245","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109037_bb0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0111","article-title":"Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies","volume":"177","author":"Yance","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109037_bb0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/dx-2018-0007","article-title":"An unusual circulating steroid profile in a virilized postmenopausal woman","volume":"5","author":"Benavent Correro","year":"2018","journal-title":"Diagnosis"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109037_bb0260","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/jc.2010-1991","article-title":"Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin","volume":"96","author":"Vollaard","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:00:51Z","timestamp":1784761251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226002148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S0378512226002148"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109037","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of androgen excess presenting after menopause","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109037"}}